IP Library Granted Patent US 12,269,484
Granted Patent B2
US 12,269,484 · App. 17/677,269 · Granted Apr 8, 2025

Systems and methods to keep drivers, pilots, or others alert or focused by electromagnetic delivery of signals

Inventors: John T. Butters (Seattle, WA); Lisa C. Butters (Seattle, WA)
Assignee: NearField Atomics Inc.
B60W40/09B60N2/0022B60N2230/20B60W2540/22B60W2540/229
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,269,484
App. No.
17/677,269
Granted
Apr 8, 2025
Kind
B2
Abstract

A system for delivery of ultra-low radio frequency energy to an individual to assist the individual to remain, or become, alert, awake, or focused includes at least one delivery coil and a delivery device that includes at least one memory; at least one data file configured for producing signals derived from measurements of at least one molecule; and at least one processor coupled to the at least one memory and the at least one delivery coil. The at least one processor is configured to perform actions that include directing generation of the signals using the at least one data file and directing delivery of the signals to the at least one delivery coil to produce the ultra-low radio frequency energy.

Claims (45)

1. A system for delivery of ultra-low radio frequency energy to an individual the system comprising:

at least one delivery coil configured for placement at an effective distance from the individual; and

a delivery device comprising

at least one memory;

at least one data file stored, or storable, in the at least one memory, the at least one data file configured for producing signals derived from measurements of at least one molecule, wherein the signals are configured to produce the ultra-low radio frequency energy when delivered to the at least one delivery coil, wherein at least one of the at least one data file is configured for producing the signals derived, at least in part, from the measurements of at least one molecule selected from nicotine, caffeine, theobromine, or any combination thereof; and

at least one processor coupled to the at least one memory and the at least one delivery coil, wherein the at least one processor is configured to perform actions, comprising

directing generation of the signals using the at least one data file, and

directing delivery of the signals to the at least one delivery coil to produce the ultra-low radio frequency energy.

2. The system of claim 1 , wherein the at least one delivery coil is disposed in or on a headrest or a seat.

3. The system of claim 1 , wherein the at least one delivery coil is disposed in or on a steering wheel.

4. The system of claim 1 , wherein the at least one delivery coil is disposed in or on a window, or windshield.

5. The system of claim 1 , further comprising at least one sensor configured for communication with the delivery device.

6. The system of claim 5 , wherein at least one of the at least one sensor is a physiological or biometric sensor.

7. The system of claim 5 , wherein at least one of the at least one sensor is a driving or flight sensor.

8. The system of claim 5 , wherein the directing generation of the signals comprises directing the generation of the signals in response to the at least one sensor.

9. The system of claim 1 , wherein the at least one processor comprises instructions for manually directing the generation of the signals by the individual.

10. The system of claim 1 , wherein at least one of the at least one data file is a data file using an audio file format.

11. A system for delivery of ultra-low radio frequency energy to an individual the system comprising:

at least one delivery coil configured for placement at an effective distance from the individual; and

a delivery device comprising

at least one memory;

at least one data file stored, or storable, in the at least one memory, the at least one data file configured for producing signals derived from measurements of at least one molecule, wherein the signals are configured to produce the ultra-low radio frequency energy when delivered to the at least one delivery coil, wherein at least one of the at least one data file is configured for producing the signals derived, at least in part, from the measurements of a combination of two or more molecules; and

at least one processor coupled to the at least one memory and the at least one delivery coil, wherein the at least one processor is configured to perform actions, comprising

directing generation of the signals using the at least one data file, and

directing delivery of the signals to the at least one delivery coil to produce the ultra-low radio frequency energy.

12. The system of claim 11 , wherein at least one of the two or more molecules is selected from nicotine, caffeine, or theobromine.

13. A system for delivery of ultra-low radio frequency energy to an individual the system comprising:

at least one delivery coil configured for placement at an effective distance from the individual;

at least one sensor configured for communication with the delivery device; and

a delivery device comprising

at least one memory;

at least one data file stored, or storable, in the at least one memory, the at least one data file configured for producing signals derived from measurements of at least one molecule, wherein the signals are configured to produce the ultra-low radio frequency energy when delivered to the at least one delivery coil; and

at least one processor coupled to the at least one memory and the at least one delivery coil, wherein the at least one processor is configured to perform actions, comprising

directing generation of the signals using the at least one data file, and

directing delivery of the signals to the at least one delivery coil to produce the ultra-low radio frequency energy,

wherein the at least one processor comprises instructions for operation of an artificial intelligence configured to receive information from the at least one sensor and determine when to generate the signals in response to the at least one sensor.

14. The system of claim 13 , wherein at least one of the at least one data file is configured for producing the signals derived, at least in part, from the measurements of a stimulant molecule.

15. The system of claim 13 , wherein at least one of the at least one data file is configured for producing the signals derived, at least in part, from the measurements of at least one molecule selected from nicotine, caffeine, theobromine, or any combination thereof.

16. The system of claim 13 , wherein the artificial intelligence is configured for determining when the individual is drowsy from the information received from the at least one sensor.

17. A method for delivery of ultra-low radio frequency energy to an individual the method comprising:

generating signals using at least one data file, wherein the at least one data file is configured for producing signals derived from measurements of at least one molecule, wherein the signals are configured to produce the ultra-low radio frequency energy when delivered to at least one delivery coil, wherein at least one of the at least one data file is configured for producing the signals derived, at least in part, from the measurements of at least one molecule selected from nicotine, caffeine, theobromine, or any combination thereof; and

directing delivery of the signals to at least one delivery coil placed at an effective distance from the individual to produce the ultra-low radio frequency energy.

18. The method of claim 17 , wherein the at least one delivery coil is disposed in or on a headrest, a seat, a steering wheel, a window, or windshield.

19. The method of claim 17 , wherein the generating the signals comprises generating of the signals in response to the at least one sensor.

20. The method of claim 17 , wherein the generating the signals comprises manually directing the generation of the signals by the individual.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 22, 2022
From: BUTTERS, JOHN T.; BUTTERS, LISA C.
To: NEARFIELD ATOMICS INC.
Reel/Frame 059064/0772 →
Continuity (4)
Provisional Application 63252986 · Oct 6, 2021
Provisional Application 63164022 · Mar 22, 2021
Provisional Application 63154532 · Feb 26, 2021
Related Publication 20220274604A1 · Sep 1, 2022
References Cited (112)
US 6541978B1 · Benveniste et al. · 2003 [cited by applicant]
US 6724188B2 · Butters et al. · 2004 [cited by applicant]
US 6952652B2 · Butters · 2005 [cited by applicant]
US 6995558B2 · Butters et al. · 2006 [cited by applicant]
US 7048890B2 · Coehoorn et al. · 2006 [cited by applicant]
US 7081747B2 · Butters et al. · 2006 [cited by applicant]
US 7412340B2 · Butters · 2008 [cited by applicant]
US 8456157B2 · Litvinov et al. · 2013 [cited by applicant]
US 8494198B2 · Aldaz et al. · 2013 [cited by applicant]
US 8838022B2 · Dobyns · 2014 [cited by applicant]
US 8929809B2 · Dobyns · 2015 [cited by applicant]
US 9300367B2 · Christensen et al. · 2016 [cited by applicant]
US 9417257B2 · Butters et al. · 2016 [cited by applicant]
US 9455771B2 · Dobyns · 2016 [cited by applicant]
US 9742471B1 · Thoen · 2017 [cited by applicant]
US 10012706B2 · Bates et al. · 2018 [cited by applicant]
US 10015623B2 · Thoen · 2018 [cited by applicant]
US 10046172B2 · Butters et al. · 2018 [cited by applicant]
US 10210409B1 · Migneco et al. · 2019 [cited by applicant]
US 10715937B2 · Haubrich et al. · 2020 [cited by applicant]
US 10939488B2 · Ng et al. · 2021 [cited by applicant]
US 11103721B2 · Butters et al. · 2021 [cited by applicant]
US 20020077537A1 · Arvin et al. · 2002 [cited by applicant]
US 20040233060A1 · Mohri · 2004 [cited by examiner]
US 20050087000A1 · Coehoorn et al. · 2005 [cited by applicant]
US 20070148670A1 · O'Malley · 2007 [cited by examiner]
US 20080097142A1 · Savage · 2008 [cited by applicant]
US 20100097186A1 · Wielebski et al. · 2010 [cited by applicant]
US 20100264917A1 · Budker et al. · 2010 [cited by applicant]
US 20100298624A1 · Becker · 2010 [cited by applicant]
US 20110148640A1 · Kang · 2011 [cited by examiner]
US 20110244599A1 · Whig et al. · 2011 [cited by applicant]
US 20120136585A1 · Apostolos · 2012 [cited by examiner]
US 20120310550A1 · Bates et al. · 2012 [cited by applicant]
US 20130261374A1 · Elder · 2013 [cited by applicant]
US 20130324786A1 · Rogachefsky · 2013 [cited by applicant]
US 20140029777A1 · Jang · 2014 [cited by applicant]
US 20140292318A1 · Wang et al. · 2014 [cited by applicant]
US 20150335288A1 · Toth · 2015 [cited by examiner]
US 20160008632A1 · Wetmore et al. · 2016 [cited by applicant]
US 20160011183A1 · Egan et al. · 2016 [cited by applicant]
US 20160028493A1 · Ohishi · 2016 [cited by examiner]
US 20160030761A1 · Butters et al. · 2016 [cited by applicant]
US 20170067969A1 · Butters et al. · 2017 [cited by applicant]
US 20170097337A1 · Schultz et al. · 2017 [cited by applicant]
US 20170117972A1 · Ishibashi · 2017 [cited by examiner]
US 20170164834A1 · Park · 2017 [cited by examiner]
US 20170207860A1 · Zhang · 2017 [cited by examiner]
US 20170244496A1 · Geurts · 2017 [cited by examiner]
US 20170266443A1 · Rajguru et al. · 2017 [cited by applicant]
US 20170343695A1 · Stetson et al. · 2017 [cited by applicant]
US 20180237850A1 · Mandell et al. · 2018 [cited by applicant]
US 20180353095A1 · Boesen · 2018 [cited by applicant]
US 20190015048A1 · Baker et al. · 2019 [cited by applicant]
US 20190143135A1 · Butters · 2019 [cited by applicant]
US 20190184188A1 · Butters et al. · 2019 [cited by applicant]
US 20190317167A1 · Laborde et al. · 2019 [cited by applicant]
US 20200086078A1 · Poltorak · 2020 [cited by examiner]
US 20200295848A1 · Kang · 2020 [cited by examiner]
US 20200326309A1 · Braganca et al. · 2020 [cited by applicant]
US 20210204867A1 · Toth · 2021 [cited by examiner]
US 20220226663A1 · Butters et al. · 2022 [cited by applicant]
US 20220257962A1 · Mogen et al. · 2022 [cited by applicant]
US 20220274604A1 · Butters · 2022 [cited by examiner]
US 20230201615A1 · Figueroa et al. · 2023 [cited by applicant]
US 20230240529A1 · Toth · 2023 [cited by examiner]
US 20240189612A1 · Butters · 2024 [cited by applicant]
DE 102014218744 · 2016 [cited by applicant]
EP 2109771B1 · 2010 [cited by applicant]
EP 2115468B1 · 2010 [cited by applicant]
EP 1566651B1 · 2013 [cited by applicant]
EP 2614770 · 2013 [cited by applicant]
EP 2800970B1 · 2016 [cited by applicant]
EP 3695878 · 2020 [cited by applicant]
WO 2014184395A9 · 2014 [cited by applicant]
WO 2019070911 · 2019 [cited by applicant]
WO 2019140404 · 2019 [cited by applicant]
WO 2019142196 · 2019 [cited by applicant]
“Theobromine,” Wikipedia, The Free Encyclopedia, https://en.wikipedia.org/wiki/theobromine (accessed Feb. 23, 2024) (Year: 2024). [cited by examiner]
“Stimulant,” Wikipedia, The Free Encyclopedia, https://en.wikipedia.org/wiki/stimulant (accessed Feb. 23, 2024) (Year: 2024). [cited by examiner]
International Search Report and Written Opinion for PCT/US2022/017246 mailed May 19, 2022. [cited by applicant]
International Search Report and Written Opinion for PCT Application No. PCT/US2022/020384 mailed Jun. 29, 2022. [cited by applicant]
Issadore D, Park Yi, Shao H, Min C, Lee K, Liong M, Weissleder R, Lee H. Magnetic sensing technology for molecular analyses. Lab Chip. Jul. 21, 2014;14(14):2385-97. doi: 10.1039/c4lc00314d. [cited by applicant]
Oogane, M., Fujiwara, K., Kanno, A., Nakano, T., Wagatsuma, H., Arimoto, T., Mizukami, S., Kumagai, S., Matsuzaki, H., Nakasato, N., & Ando, Y. (2021). Sub-pT magnetic field detection by tunnel magneto-resistive sensors… [cited by applicant]
Richard S. Gaster; Giant Magnetoresistive Nanosensors for Ultrasensitive In Vitro Diagnostics and Biomolecular Kinetics. Dissertation submitted to Stanford University, Nov. 2011; 163 pages. Available on-line at https://… [cited by applicant]
Adem S, Jain S, Sveiven M, Zhou X, O'Donoghue AJ, Hall DA. Giant magnetoresistive biosensors for real-time quantitative detection of protease activity. Sci Rep. May 14, 2020;10(1):7941. doi: 10.1038/s41598-020-62910-2. … [cited by applicant]
Wang, W., Wang, Y., Tu, L. et al. Magnetoresistive performance and comparison of supermagnetic nanoparticles on giant magnetoresistive sensor-based detection system. Sci Rep 4, 5716 (2014). https://doi.org/10.1038/srep0… [cited by applicant]
Rizzi, G., Dufva, M. & Hansen, M. Magnetoresistive sensors for measurements of DNA hybridization kinetics—effect of TINA modifications. Sci Rep 7, 41940 (2017). https://doi.org/10.1038/srep41940. [cited by applicant]
Trisnanto, Suko & Kasajima, Tamon & Akushichi, Taiju & Takemura, Yasushi. (2021). Magnetic particle imaging using linear magnetization response-driven harmonic signal of magnetoresistive sensor. Applied Physics Express.… [cited by applicant]
Ioanna Giouroudi and Evangelos Hristoforou , “Perspective: Magnetoresistive sensors for biomedicine”, Journal of Applied Physics 124, 030902 (2018) https://doi.org/10.1063/1.5027035. [cited by applicant]
Baselt DR, Lee GU, Natesan M, Metzger SW, Sheehan PE, Colton RJ. A biosensor based on magnetoresistance technology. Biosens Bioelectron. Oct. 1, 1998;13(7-8):731-9. doi: 10.1016/s0956-5663(98)00037-2. PMID: 9828367. [cited by applicant]
Yao, Li & Xu, Shoujun. (2014). Detection of magnetic nanomaterials in molecular imaging and diagnosis applications. Nanotechnology Reviews. 3. 247-268. 10.1515/ntrev-2013-0044. [cited by applicant]
Yin, T.-I & Paul, J. & Lehndorff, Ronald. (2016). 3.3.1—Magnetoresistive Sensors for the Application in Biotechnology. 190-194. 10.5162/sensoren2016/3.3.1. [cited by applicant]
Shirai Y, Hirao K, Shibuya T, Okawa S, Hasegawa Y, Adachi Y, Sekihara K, Kawabata S. Magnetocardiography Using a Magnetoresistive Sensor Array. Int Heart J. Jan. 25, 2019;60(1):50-54. doi: 10.1536/ihj. 18-002. Epub Nov.… [cited by applicant]
Smith, C.H., & Schneider, R.W. (2000). GMR and SDT Sensors and Arrays for LowField Magnetic Applications. Nonvolatile Electronics, Inc. 12 pages. [cited by applicant]
Bae, Seongtae. (2010). In-Vitro Magnetoresistive Biosensors for Single Molecular Based Disease Diagnostics: Optimization of Sensor Geometry and Structure. 10.5772/6870. [cited by applicant]
Henriksen, Anders & Ley, Mikkel & Flyvbjerg, Henrik & Hansen, Mikkel. (2015). Configurational Statistics of Magnetic Bead Detection with Magnetoresistive Sensors. PloS one. 10. e0141115. 10.1371/journal.pone.0141115. [cited by applicant]
Reiss, Guenter & Brückl, Hubert & Hutten, Andreas & Schotter, Joerg & Brzeska, Monika & Panhorst, Michael & Sudfeld, Daniela & Becker, Anke & Kamp, Paul-Bertram & Puehler, Alfred & Wojczykowski, Klaus & Jutzi, Peter. (2… [cited by applicant]
Su D, Wu K, Saha R, Peng C, Wang JP. Advances in Magnetoresistive Biosensors. Micromachines (Basel). Dec. 26, 2019;11(1):34. doi: 10.3390/mi11010034. PMID: 31888076; PMCID: PMC7019276. [cited by applicant]
Ulasov IV, Foster H, Butters M, Yoon JG, Ozawa T, Nicolaides T, Figueroa X, Hothi P, Prados M, Butters J, Cobbs C. Precision knockdown of EGFR gene expression using radio frequency electromagnetic energy. J Neurooncol. … [cited by applicant]
Butters, John & Figueroa, Xavier & Butters, Bennett. (2014). Non-Thermal Radio Frequency Stimulation of Tubulin Polymerization in Vitro: A Potential Therapy for Cancer Treatment. Open Journal of Biophysics. 04. 147. 10.… [cited by applicant]
Mukthavaram R, Jiang P, Nomura N, et al. ATPS-64: Preclinical Studies Using Nativis Voyager RFE System, a Novel Non-Invasive, Low Energy, Non-Thermal, Non-Ionizing Radiofrequency Energy (RFE) Device in Glioblastoma Mous… [cited by applicant]
Cobbs C, McClay E, Duic JP, Nabors LB, Morgan Murray D, Kesari S. An early feasibility study of the Nativis Voyager® device in patients with recurrent glioblastoma: first cohort in US. CNS Oncol. Mar. 2019;8(1):CNS30. d… [cited by applicant]
Murphy M, Dowling A, Thien C, Priest E, Morgan Murray D, Kesari S. A feasibility study of the Nativis Voyager® device in patients with recurrent glioblastoma in Australia. CNS Oncol. Mar. 2019;8(1):CNS31. doi: 10.2217/c… [cited by applicant]
Ulasov, Ilya & Ghosh, Dhimankrishna & Butters, Mike & Butters, John & Cobbs, Charles. (2016). EXTH-50. Specific Knockdown of EGFR and PLK1 Gene Expression in U87 GBM Cells With Radiofrequency Energy (RFE) Device. Japan … [cited by applicant]
Butters, Bennett & Vogeli, Gabriel & Figueroa, Xavier. (2017). Non-Thermal Radio Frequency Stimulation Inhibits the Tryptophan Synthase Beta Subunit in the Algae Chlamydomonas reinhardtii. Open Journal of Biophysics. 07… [cited by applicant]
Figueroa, Xavier; Green, Yesenia; Murray, Donna Morgan; and Butters, Mike. Effects of Magnetic Fields on Biological Systems, An Overview. EMulate Therapeutics, Mar. 6, 2020. 8 pages. [cited by applicant]
Figueroa, Xavier & Butters, Mike & Donnell, Scott. (2019). SCIDOT-47. Effect of uIRFE Cognates Emulating Bioactive Substances on Animal Behavior. Neuro-Oncology. 21. vi281-vi282. 10.1093/neuonc/noz175.1183. [cited by applicant]
Specification of U.S. Appl. No. 17/695,482, filed Mar. 15, 2022. [cited by applicant]
Press Release for “Hapbee Announces Filing of Provisional Patent Application for Bed-Related Form Factor,” Feb. 19, 2021, found at https://hapbee.com/blogs/hapbee/hapbee-announces-filing-of-provisional-patent-applicatio… [cited by applicant]
Andrew Kelly, “Integrated Circuit Design for Miniature Implantable Medical Devices,” Presented at the Embedded Systems Conference at Design East in Boston, MA. Sep. 18, 2012. 14 pages. [cited by applicant]
Kim, Han-Joon, et al. “Review of near-field wireless power and communication for biomedical applications.” IEEE Access, vol. 5, 2017, pp. 21264-21285, https://doi.org/10.1109/access.2017.2757267. (Year: 2017). [cited by applicant]